Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care portfolio and leveraging its expertise in ...
2009 NOV 16 ... Investigators publish new data in the report 'Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and ...
2009 NOV 30 ... withdrawal after 48 h exposure led to inhibition of ERK1/2 phosphorylation. Carbacol and nerve growth factor (NGF), which are ERK1/2 activators, protected the neurons after CPF withdrawal, while ...
2009 NOV 24 ... cultured sympathetic neurons, overexpression of DeltaNp73 inhibits apoptosis induced by nerve growth factor withdrawal or p53 overexpression. To probe the function of DeltaNp73 in vivo, we ...
2009 NOV 16 ... show that transcription corepressor CtBP2 directly binds acinus, which is regulated by nerve growth factor (NGF), inhibiting its stimulatory effect on cyclin A1, but not cyclin A2, expression in ...
2009 NOV 30 ... and one extra-adrenal paraganglioma showed RET induction corresponding with extensive nerve growth factor-induced outgrowth of neurite-like processes, while one pheochromocytoma showed neither ...
2009 NOV 17 ... quercetin (Q) (12.5 or 25 mc M), luteolin (L) (25 mc M), Q + L (12.5 mu m each one) or nerve growth factor (NGF) for 3 days. Four morphological parameters (percentage of cells with neurites ...
2009 NOV 23 ... an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), announced it has entered into an agreement with Abbott (NYSE: ABT) under which ...
2009 NOV 17 ... surface inflammatory diseases," researchers in Rome, Italy report. "Nerve growth factor (NGF) plays a crucial role in healing and inflammation of the ocular surface. The aim of ...
2009 NOV 10 ... abolition and necrosis of neurons as well as necrosis and apoptosis of glial cells. Nerve growth factor but not brain-derived neurotrophic factor or epidermal growth factor protected glial ...
2009 NOV 16 ... brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), and nerve growth factor (NGF) might be involved in the pathophysiology of neuropathic pain," scientists writing ...
2009 NOV 9 ... in axons. Anterograde TrkA delivery and exocytosis into axon growth cones is enhanced by nerve growth factor (NGF), acting locally on distal axons. Perturbing endocytic recycling attenuated ...
2009 NOV 16 ... ganglion neurone culture system consisting of Matrigel and a Boyden chamber containing a nerve growth factor (NGF) concentration gradient was used. In some experiments, matrix metalloproteinase ...
2009 NOV 16 ... correlating with the presence of the neurotrophins brain derived neurotrophic factor, nerve growth factor and neurotrophin-3 in the supernatant and increased intracellular cyclic adenosine ...
2009 NOV 30 ... Additionally, despite numerous past failures of drugs aimed at improving nerve function in patients with diabetic neuropathy, several drugs for the indication that are ... Nephropathy finds that the diabetic retinopathy drug market will experience the greatest growth, increasing by more than 60 percent annually through 2013 and by more than 40 percent ... the diabetic retinopathy market, the use of drugs from the vascular endothelial growth factor (VEGF) inhibitors class will expand significantly following the approval of several VEGF ...
2009 NOV 23 ... receptor (IL-6R), being developed for the treatment of rheumatoid arthritis, (2) Nerve Growth Factor, being developed for the treatment of pain, and (3) Delta-like Ligand 4 (Dll4), being ...
2009 NOV 9 ... healthy states and in diseases such as bronchial asthma. Recent studies have shown that nerve growth factor (NGF) is expressed in various non-neuronal cells." "Furthermore, little ...
2009 NOV 16 ... cancer gene therapy. According to recent research from London, the United Kingdom, "The nerve growth factor (NGF) receptor, trkA, the tumor suppressor p53 and the phosphatase SHP-1 are critical in ...
2009 NOV 23 ... etiology of arrhythmias resulting in sudden cardiac death. Previous studies show that nerve growth factor (NGF) is essential for enhanced post-infarct sympathetic sprouting, but the cell types ...
2009 NOV 16 ... AF. The average length of growing axons in the NP was significantly shortened after anti-nerve growth factor (NGF)beta treatment (P < 0.005); however, that in the AF was not (P < 0.05). The ...
